Order process and results
Don’t settle for ambiguity
DiffDx-Melanoma easily integrates into your diagnostic process. Ordering and obtaining results are straightforward. A new biopsy is not required.
Demonstrated diagnostic performance
Accuracy metrics
DecisionDx DiffDx-Melanoma provides a highly accurate and objective evaluation resulting in a benign or malignant result in >96% of lesions receiving a test result.
99.1% Sensitivity 95% Cl: 97.9-100 | 94.3% Specificity 95% Cl: 91.5-97.1 | 93.6% PPV 95% Cl: 90.5-96.7 |
99.2% NPV 95% Cl: 98.1-100 | 3.6% Intermediate Risk |
Diagnostic goals in sharper resolution
- Create a clinically actionable pathology report in more cases
- Inform more appropriate management plans for dermatologists and their patients
- Obtain diagnostic confidence: Your patient is receiving a diagnosis aided by objective and dependable gene expression analysis
- Provide your patient with a more clinically actionable diagnosis
- Implement more appropriate patient management plans
- Enhance clinical confidence: your patient is receiving the appropriate treatment based on a clinically validated, objective evaluation